Aspergillus flavus is a type of saprophytic soil fungus that can cause various health problems, including allergic reactions, aspergillosis, and fungal infections. The epidemiology of A. flavus can vary depending on several factors, including geographic location, environmental conditions, and individual risk factors.
Some key points about the epidemiology of A. flavus are:
Aspergillus flavus is commonly found in soil, decaying vegetation, and grains, such as corn, peanuts, and other crops.
Infection with A. flavus is more common in tropical and subtropical regions, where the fungus thrives in warm and humid conditions.
Individuals with weakened immune systems, like those with HIV/AIDS, cancer, or organ transplants, are at increased risk of developing aspergillosis from A. flavus.
Exposure to A. flavus can occur through inhalation of spores, ingesting contaminated food, or contact with contaminated objects or surfaces. Aspergillus flavus also produces aflatoxins, carcinogenic toxins that can contaminate food and cause liver cancer.
Aspergillus flavus is responsible for up to 20% of all cases of invasive aspergillosis, a severe fungal infection that can affect the lungs, brain, or other organs.
In developing countries, where food storage and processing conditions may be suboptimal, up to 40% of crops may be contaminated with A. flavus, leading to increased exposure to aflatoxins.
Aflatoxins produced by A. flavus are estimated to cause up to 155,000 cases of liver cancer each year worldwide. It was reported World Health Organization.
International Journal of Food Microbiology released a study of fungal contamination of spices in India; 57% of samples were contaminated with Aspergillus flavus, with contamination levels ranging from 10-9,000 CFU/g (colony-forming units per gram). A Respiratory study of medicine found that in patients with chronic obstructive pulmonary disease (COPD), Aspergillus flavus was isolated from the sputum of 22.8% of patients.
Kingdom: Fungi
Division: Ascomycota
Subdivision: Pezizomycotina
Class: Eurotiomycetes
Order: Eurotiales
Family: Aspergillaceae
Genus: Aspergillus
Species: Aspergillus flavus
Structure:
Aspergillus flavus is a filamentous fungus with a complex structure with several distinct components. Here are some of the structural components of Aspergillus flavus:
Hyphae: Aspergillus flavus has long, thread-like structures called hyphae, composed of a branching filaments network. The hyphae grow from the spores and penetrate the substrate, allowing the fungus to obtain nutrients and spread.
A. flavus produces asexual spores called conidia, small, single-celled structures dispersed by the wind. The conidia are essential for the dispersal and survival of the fungus.
Sclerotia:A. flavus can produce compact, hardened structures called sclerotia, composed of dense mycelia, and serve as a survival mechanism during periods of stress or unfavorable conditions.
Mycelium:Aspergillus flavus has a complex network of branching filaments called mycelium, which grow through the substrate and absorb environmental nutrients.
It has a cell wall composed of chitin, glucans, and other polysaccharides.
A. flavus produces specialized structures called sporangiophores, which are responsible for producing and releasing sexual spores.
Aspergillus flavus also produces spherical structures called cysts, responsible for producing and releasing asexual conidia.
In some strains of A. flavus, specialized cells called Hülle cells are present on the surface of the conidia. These cells are thought to play a role in protecting the conidia from environmental stressors.
Type I Aspergillus flavus strains are commonly associated with human and animal infections and tend to produce high levels of the potent hepatocarcinogenic toxin, aflatoxin. Type I strains are often found in warmer regions, such as the south-eastern United States, sub-Saharan Africa, and Asia.
On the other hand, type II Aspergillus flavus strains are less frequently associated with human and animal infections and tend to produce lower levels of aflatoxin. Type II strains are more prevalent in cooler regions, such as Europe and northern Asia.
Other antigenic A. flavus, such as type III and IV, have been identified. Their clinical significance still needs to be fully understood, and they are less well characterized than type I and type II strains.
Aspergillus flavus spores can adhere to the host epithelial cells in the respiratory or gastrointestinal tract using various adhesion molecules and receptors. Once attached, the spores can germinate and produce hyphae that invade the host tissues, using enzymes such as proteases, phospholipases, and elastases to degrade the host extracellular matrix.
A. flavus can evade the host immune system by several mechanisms, such as masking its cell wall antigens, producing mycotoxins that suppress immune cells, or altering the cytokine profile of the host response. The fungus can also form biofilms that protect it from immune cells and antifungal drugs.
A. flavus can produce several mycotoxins, such as aflatoxins, that can damage the host cells and tissues, leading to inflammation, necrosis, and cancer. Aflatoxins are potent carcinogens that can cause liver cancer in humans and animals.
Aspergillus flavus can disseminate to other organs, such as the brain, kidneys, or liver, through the bloodstream or lymphatic system, causing systemic infections or multi-organ failure.
Innate immune response:
a) Recognition of Aspergillus flavus: When A. flavus spores enter the body, they are recognized by the pattern recognition receptors (PRRs) on the surface of the innate immune cells, such as dendritic cells, macrophages, and neutrophils. The PRRs include Toll-like receptors (TLRs), which recognize specific pathogen-associated molecular patterns (PAMPs) on the surface of A. flavus spores, and NOD-like receptors (NLRs), which recognize the fungal components in the cytosol of the cells.
b) Activation of innate immune cells: Upon recognizing A. flavus, the innate immune cells are activated and secrete cytokines, chemokines, and antimicrobial peptides that recruit and activate other immune cells at the site of infection. Neutrophils are the first cells to be recruited, and they phagocytose and kill the fungal spores by producing reactive oxygen species (ROS) and releasing antimicrobial peptides.
c) Interference with an innate immune response: A. flavus can interfere with the innate immune response by producing various virulence factors, such as gliotoxin, that can suppress immune function and inhibit the activity of neutrophils and macrophages.
Adaptive immune response:
a) Activation of T cells: Once the A. flavus spores are phagocytosed by the innate immune cells, they are processed and presented to the T cells by the antigen-presenting cells (APCs) in the lymph nodes. The T cells recognize the fungal antigens through their T cell receptors (TCRs) and become activated.
b) Differentiation of T cells: The activated T cells differentiate into various subsets, including CD4+ T helper cells and CD8+ cytotoxic T cells, depending on the type of antigen presented and the cytokine milieu. CD4+ T helper cells differentiate into Th1, Th2, Th17, or Treg cells, which secrete cytokines that help to activate other immune cells and control the immune response to A.
c) Production of antibodies: B cells are activated by the Aspergillus flavus antigens and differentiate into plasma cells, which produce antibodies that can bind to and neutralize the fungus.
d) Immune memory: Once the immune response has cleared the Aspergillus flavus infection, memory T and B cells are generated to recognize the fungus upon re-exposure and mount a more rapid and effective response.
Aspergillus flavus is known to cause various diseases in humans and animals, including invasive aspergillosis, non-invasive aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis.
Invasive pulmonary aspergillosis: Aspergillus flavus is one of the most common causes of invasive pulmonary aspergillosis (IPA), a severe fungal infection of the lungs that can occur in immunocompromised patients, such as those with leukemia, lymphoma, or undergoing bone marrow transplantation. IPA can cause symptoms such as cough, fever, chest pain, shortness of breath, and hemoptysis. The infection can spread to other organs, such as the brain, kidneys, or liver, leading to multi-organ failure.
Sinusitis: It is a fungal infection of the sinuses that can cause nasal congestion, facial pain, headache, and fever. The infection can spread to the eye or brain, causing vision loss or neurological symptoms.
Otitis externa: An outer ear canal infection that can cause pain, itching, and discharge.
Onychomycosis: The infection of the nails that express discoloration, thickening, and separation of the nail from the nail bed.
Cutaneous infections: A. flavus can cause cutaneous infections, such as folliculitis, abscesses, or cellulitis, in immunocompromised patients.
Allergic bronchopulmonary aspergillosis: In some patients, A. flavus can cause a hypersensitivity reaction to the fungal antigens that can cause wheezing, coughing, and shortness of breath.
Diagnosing Aspergillus flavus infection requires a combination of clinical features, radiological findings, and laboratory tests. Here are some of the standard methods for diagnosing A. flavus infection:
Fungal culture: It is the gold standard for diagnosing A. flavus infection. Using selective fungal media, the fungus can be isolated from clinical specimens, such as sputum, bronchoalveolar lavage (BAL) fluid, blood, or tissues. The culture can be confirmed by microscopic examination and species identification using molecular or biochemical methods.
Antigen detection: A. flavus produces several cell wall antigens that can be detected in infected patients’ serum or BAL fluid using immunoassays such as enzyme-linked immunosorbent assay (ELISA). The most used antigen is galactomannan, a polysaccharide specific to Aspergillus species.
Molecular assays: Assays, such as polymerase chain reaction (PCR) or real-time PCR, can detect Aspergillus DNA in clinical specimens with high sensitivity and specificity. These assays can also differentiate between Aspergillus species and detect mutations that confer resistance to antifungal drugs.
Imaging studies: Imaging studies, such as chest X-ray, computed tomography (CT), or magnetic resonance imaging (MRI), can detect the characteristic features of A. flavus infection, such as nodules, cavities, or infiltrates. These studies can also assess the extent and severity of the infection and guide the treatment selection.
Histopathology: It can provide a definitive diagnosis of A. flavus infection by demonstrating the presence of fungal elements, such as hyphae, spores, or tissue invasion, in biopsy or autopsy specimens. Histopathology can also identify the host response to the infection, such as necrosis, granulomatous inflammation, or angioinvasion.
Proper storage and handling of food products:A. flavus can contaminate crops and food products, such as nuts, grains, and spices, during storage and handling. Storing food products in cool and dry environments is essential to prevent contamination. Inspecting them regularly for signs of mold growth or spoilage and discarding any contaminated or expired items.
Proper ventilation and maintenance of indoor environments:A. flavus can grow in damp or poorly ventilated indoor environments, such as bathrooms, kitchens, and basements. Maintaining proper ventilation and humidity levels is crucial to prevent its growth, repair leaks or water damage, and regularly clean and disinfect surfaces.
Personal hygiene:A. flavus can also spread from person to person through contact with contaminated surfaces or respiratory secretions. To prevent transmission, practicing good personal hygiene, such as washing hands regularly, covering coughs and sneezes, and avoiding close contact with sick individuals, is essential.
Use of antifungal agents: These are used to control Aspergillus flavus in agricultural and industrial settings, such as in the production of crops or building materials. These agents can prevent the growth and spread of the fungus and reduce the risk of exposure to workers and consumers.
Aspergillus flavus is a type of saprophytic soil fungus that can cause various health problems, including allergic reactions, aspergillosis, and fungal infections. The epidemiology of A. flavus can vary depending on several factors, including geographic location, environmental conditions, and individual risk factors.
Some key points about the epidemiology of A. flavus are:
Aspergillus flavus is commonly found in soil, decaying vegetation, and grains, such as corn, peanuts, and other crops.
Infection with A. flavus is more common in tropical and subtropical regions, where the fungus thrives in warm and humid conditions.
Individuals with weakened immune systems, like those with HIV/AIDS, cancer, or organ transplants, are at increased risk of developing aspergillosis from A. flavus.
Exposure to A. flavus can occur through inhalation of spores, ingesting contaminated food, or contact with contaminated objects or surfaces. Aspergillus flavus also produces aflatoxins, carcinogenic toxins that can contaminate food and cause liver cancer.
Aspergillus flavus is responsible for up to 20% of all cases of invasive aspergillosis, a severe fungal infection that can affect the lungs, brain, or other organs.
In developing countries, where food storage and processing conditions may be suboptimal, up to 40% of crops may be contaminated with A. flavus, leading to increased exposure to aflatoxins.
Aflatoxins produced by A. flavus are estimated to cause up to 155,000 cases of liver cancer each year worldwide. It was reported World Health Organization.
International Journal of Food Microbiology released a study of fungal contamination of spices in India; 57% of samples were contaminated with Aspergillus flavus, with contamination levels ranging from 10-9,000 CFU/g (colony-forming units per gram). A Respiratory study of medicine found that in patients with chronic obstructive pulmonary disease (COPD), Aspergillus flavus was isolated from the sputum of 22.8% of patients.
Kingdom: Fungi
Division: Ascomycota
Subdivision: Pezizomycotina
Class: Eurotiomycetes
Order: Eurotiales
Family: Aspergillaceae
Genus: Aspergillus
Species: Aspergillus flavus
Structure:
Aspergillus flavus is a filamentous fungus with a complex structure with several distinct components. Here are some of the structural components of Aspergillus flavus:
Hyphae: Aspergillus flavus has long, thread-like structures called hyphae, composed of a branching filaments network. The hyphae grow from the spores and penetrate the substrate, allowing the fungus to obtain nutrients and spread.
A. flavus produces asexual spores called conidia, small, single-celled structures dispersed by the wind. The conidia are essential for the dispersal and survival of the fungus.
Sclerotia:A. flavus can produce compact, hardened structures called sclerotia, composed of dense mycelia, and serve as a survival mechanism during periods of stress or unfavorable conditions.
Mycelium:Aspergillus flavus has a complex network of branching filaments called mycelium, which grow through the substrate and absorb environmental nutrients.
It has a cell wall composed of chitin, glucans, and other polysaccharides.
A. flavus produces specialized structures called sporangiophores, which are responsible for producing and releasing sexual spores.
Aspergillus flavus also produces spherical structures called cysts, responsible for producing and releasing asexual conidia.
In some strains of A. flavus, specialized cells called Hülle cells are present on the surface of the conidia. These cells are thought to play a role in protecting the conidia from environmental stressors.
Type I Aspergillus flavus strains are commonly associated with human and animal infections and tend to produce high levels of the potent hepatocarcinogenic toxin, aflatoxin. Type I strains are often found in warmer regions, such as the south-eastern United States, sub-Saharan Africa, and Asia.
On the other hand, type II Aspergillus flavus strains are less frequently associated with human and animal infections and tend to produce lower levels of aflatoxin. Type II strains are more prevalent in cooler regions, such as Europe and northern Asia.
Other antigenic A. flavus, such as type III and IV, have been identified. Their clinical significance still needs to be fully understood, and they are less well characterized than type I and type II strains.
Aspergillus flavus spores can adhere to the host epithelial cells in the respiratory or gastrointestinal tract using various adhesion molecules and receptors. Once attached, the spores can germinate and produce hyphae that invade the host tissues, using enzymes such as proteases, phospholipases, and elastases to degrade the host extracellular matrix.
A. flavus can evade the host immune system by several mechanisms, such as masking its cell wall antigens, producing mycotoxins that suppress immune cells, or altering the cytokine profile of the host response. The fungus can also form biofilms that protect it from immune cells and antifungal drugs.
A. flavus can produce several mycotoxins, such as aflatoxins, that can damage the host cells and tissues, leading to inflammation, necrosis, and cancer. Aflatoxins are potent carcinogens that can cause liver cancer in humans and animals.
Aspergillus flavus can disseminate to other organs, such as the brain, kidneys, or liver, through the bloodstream or lymphatic system, causing systemic infections or multi-organ failure.
Innate immune response:
a) Recognition of Aspergillus flavus: When A. flavus spores enter the body, they are recognized by the pattern recognition receptors (PRRs) on the surface of the innate immune cells, such as dendritic cells, macrophages, and neutrophils. The PRRs include Toll-like receptors (TLRs), which recognize specific pathogen-associated molecular patterns (PAMPs) on the surface of A. flavus spores, and NOD-like receptors (NLRs), which recognize the fungal components in the cytosol of the cells.
b) Activation of innate immune cells: Upon recognizing A. flavus, the innate immune cells are activated and secrete cytokines, chemokines, and antimicrobial peptides that recruit and activate other immune cells at the site of infection. Neutrophils are the first cells to be recruited, and they phagocytose and kill the fungal spores by producing reactive oxygen species (ROS) and releasing antimicrobial peptides.
c) Interference with an innate immune response: A. flavus can interfere with the innate immune response by producing various virulence factors, such as gliotoxin, that can suppress immune function and inhibit the activity of neutrophils and macrophages.
Adaptive immune response:
a) Activation of T cells: Once the A. flavus spores are phagocytosed by the innate immune cells, they are processed and presented to the T cells by the antigen-presenting cells (APCs) in the lymph nodes. The T cells recognize the fungal antigens through their T cell receptors (TCRs) and become activated.
b) Differentiation of T cells: The activated T cells differentiate into various subsets, including CD4+ T helper cells and CD8+ cytotoxic T cells, depending on the type of antigen presented and the cytokine milieu. CD4+ T helper cells differentiate into Th1, Th2, Th17, or Treg cells, which secrete cytokines that help to activate other immune cells and control the immune response to A.
c) Production of antibodies: B cells are activated by the Aspergillus flavus antigens and differentiate into plasma cells, which produce antibodies that can bind to and neutralize the fungus.
d) Immune memory: Once the immune response has cleared the Aspergillus flavus infection, memory T and B cells are generated to recognize the fungus upon re-exposure and mount a more rapid and effective response.
Aspergillus flavus is known to cause various diseases in humans and animals, including invasive aspergillosis, non-invasive aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis.
Invasive pulmonary aspergillosis: Aspergillus flavus is one of the most common causes of invasive pulmonary aspergillosis (IPA), a severe fungal infection of the lungs that can occur in immunocompromised patients, such as those with leukemia, lymphoma, or undergoing bone marrow transplantation. IPA can cause symptoms such as cough, fever, chest pain, shortness of breath, and hemoptysis. The infection can spread to other organs, such as the brain, kidneys, or liver, leading to multi-organ failure.
Sinusitis: It is a fungal infection of the sinuses that can cause nasal congestion, facial pain, headache, and fever. The infection can spread to the eye or brain, causing vision loss or neurological symptoms.
Otitis externa: An outer ear canal infection that can cause pain, itching, and discharge.
Onychomycosis: The infection of the nails that express discoloration, thickening, and separation of the nail from the nail bed.
Cutaneous infections: A. flavus can cause cutaneous infections, such as folliculitis, abscesses, or cellulitis, in immunocompromised patients.
Allergic bronchopulmonary aspergillosis: In some patients, A. flavus can cause a hypersensitivity reaction to the fungal antigens that can cause wheezing, coughing, and shortness of breath.
Diagnosing Aspergillus flavus infection requires a combination of clinical features, radiological findings, and laboratory tests. Here are some of the standard methods for diagnosing A. flavus infection:
Fungal culture: It is the gold standard for diagnosing A. flavus infection. Using selective fungal media, the fungus can be isolated from clinical specimens, such as sputum, bronchoalveolar lavage (BAL) fluid, blood, or tissues. The culture can be confirmed by microscopic examination and species identification using molecular or biochemical methods.
Antigen detection: A. flavus produces several cell wall antigens that can be detected in infected patients’ serum or BAL fluid using immunoassays such as enzyme-linked immunosorbent assay (ELISA). The most used antigen is galactomannan, a polysaccharide specific to Aspergillus species.
Molecular assays: Assays, such as polymerase chain reaction (PCR) or real-time PCR, can detect Aspergillus DNA in clinical specimens with high sensitivity and specificity. These assays can also differentiate between Aspergillus species and detect mutations that confer resistance to antifungal drugs.
Imaging studies: Imaging studies, such as chest X-ray, computed tomography (CT), or magnetic resonance imaging (MRI), can detect the characteristic features of A. flavus infection, such as nodules, cavities, or infiltrates. These studies can also assess the extent and severity of the infection and guide the treatment selection.
Histopathology: It can provide a definitive diagnosis of A. flavus infection by demonstrating the presence of fungal elements, such as hyphae, spores, or tissue invasion, in biopsy or autopsy specimens. Histopathology can also identify the host response to the infection, such as necrosis, granulomatous inflammation, or angioinvasion.
Proper storage and handling of food products:A. flavus can contaminate crops and food products, such as nuts, grains, and spices, during storage and handling. Storing food products in cool and dry environments is essential to prevent contamination. Inspecting them regularly for signs of mold growth or spoilage and discarding any contaminated or expired items.
Proper ventilation and maintenance of indoor environments:A. flavus can grow in damp or poorly ventilated indoor environments, such as bathrooms, kitchens, and basements. Maintaining proper ventilation and humidity levels is crucial to prevent its growth, repair leaks or water damage, and regularly clean and disinfect surfaces.
Personal hygiene:A. flavus can also spread from person to person through contact with contaminated surfaces or respiratory secretions. To prevent transmission, practicing good personal hygiene, such as washing hands regularly, covering coughs and sneezes, and avoiding close contact with sick individuals, is essential.
Use of antifungal agents: These are used to control Aspergillus flavus in agricultural and industrial settings, such as in the production of crops or building materials. These agents can prevent the growth and spread of the fungus and reduce the risk of exposure to workers and consumers.
Aspergillus flavus is a type of saprophytic soil fungus that can cause various health problems, including allergic reactions, aspergillosis, and fungal infections. The epidemiology of A. flavus can vary depending on several factors, including geographic location, environmental conditions, and individual risk factors.
Some key points about the epidemiology of A. flavus are:
Aspergillus flavus is commonly found in soil, decaying vegetation, and grains, such as corn, peanuts, and other crops.
Infection with A. flavus is more common in tropical and subtropical regions, where the fungus thrives in warm and humid conditions.
Individuals with weakened immune systems, like those with HIV/AIDS, cancer, or organ transplants, are at increased risk of developing aspergillosis from A. flavus.
Exposure to A. flavus can occur through inhalation of spores, ingesting contaminated food, or contact with contaminated objects or surfaces. Aspergillus flavus also produces aflatoxins, carcinogenic toxins that can contaminate food and cause liver cancer.
Aspergillus flavus is responsible for up to 20% of all cases of invasive aspergillosis, a severe fungal infection that can affect the lungs, brain, or other organs.
In developing countries, where food storage and processing conditions may be suboptimal, up to 40% of crops may be contaminated with A. flavus, leading to increased exposure to aflatoxins.
Aflatoxins produced by A. flavus are estimated to cause up to 155,000 cases of liver cancer each year worldwide. It was reported World Health Organization.
International Journal of Food Microbiology released a study of fungal contamination of spices in India; 57% of samples were contaminated with Aspergillus flavus, with contamination levels ranging from 10-9,000 CFU/g (colony-forming units per gram). A Respiratory study of medicine found that in patients with chronic obstructive pulmonary disease (COPD), Aspergillus flavus was isolated from the sputum of 22.8% of patients.
Kingdom: Fungi
Division: Ascomycota
Subdivision: Pezizomycotina
Class: Eurotiomycetes
Order: Eurotiales
Family: Aspergillaceae
Genus: Aspergillus
Species: Aspergillus flavus
Structure:
Aspergillus flavus is a filamentous fungus with a complex structure with several distinct components. Here are some of the structural components of Aspergillus flavus:
Hyphae: Aspergillus flavus has long, thread-like structures called hyphae, composed of a branching filaments network. The hyphae grow from the spores and penetrate the substrate, allowing the fungus to obtain nutrients and spread.
A. flavus produces asexual spores called conidia, small, single-celled structures dispersed by the wind. The conidia are essential for the dispersal and survival of the fungus.
Sclerotia:A. flavus can produce compact, hardened structures called sclerotia, composed of dense mycelia, and serve as a survival mechanism during periods of stress or unfavorable conditions.
Mycelium:Aspergillus flavus has a complex network of branching filaments called mycelium, which grow through the substrate and absorb environmental nutrients.
It has a cell wall composed of chitin, glucans, and other polysaccharides.
A. flavus produces specialized structures called sporangiophores, which are responsible for producing and releasing sexual spores.
Aspergillus flavus also produces spherical structures called cysts, responsible for producing and releasing asexual conidia.
In some strains of A. flavus, specialized cells called Hülle cells are present on the surface of the conidia. These cells are thought to play a role in protecting the conidia from environmental stressors.
Type I Aspergillus flavus strains are commonly associated with human and animal infections and tend to produce high levels of the potent hepatocarcinogenic toxin, aflatoxin. Type I strains are often found in warmer regions, such as the south-eastern United States, sub-Saharan Africa, and Asia.
On the other hand, type II Aspergillus flavus strains are less frequently associated with human and animal infections and tend to produce lower levels of aflatoxin. Type II strains are more prevalent in cooler regions, such as Europe and northern Asia.
Other antigenic A. flavus, such as type III and IV, have been identified. Their clinical significance still needs to be fully understood, and they are less well characterized than type I and type II strains.
Aspergillus flavus spores can adhere to the host epithelial cells in the respiratory or gastrointestinal tract using various adhesion molecules and receptors. Once attached, the spores can germinate and produce hyphae that invade the host tissues, using enzymes such as proteases, phospholipases, and elastases to degrade the host extracellular matrix.
A. flavus can evade the host immune system by several mechanisms, such as masking its cell wall antigens, producing mycotoxins that suppress immune cells, or altering the cytokine profile of the host response. The fungus can also form biofilms that protect it from immune cells and antifungal drugs.
A. flavus can produce several mycotoxins, such as aflatoxins, that can damage the host cells and tissues, leading to inflammation, necrosis, and cancer. Aflatoxins are potent carcinogens that can cause liver cancer in humans and animals.
Aspergillus flavus can disseminate to other organs, such as the brain, kidneys, or liver, through the bloodstream or lymphatic system, causing systemic infections or multi-organ failure.
Innate immune response:
a) Recognition of Aspergillus flavus: When A. flavus spores enter the body, they are recognized by the pattern recognition receptors (PRRs) on the surface of the innate immune cells, such as dendritic cells, macrophages, and neutrophils. The PRRs include Toll-like receptors (TLRs), which recognize specific pathogen-associated molecular patterns (PAMPs) on the surface of A. flavus spores, and NOD-like receptors (NLRs), which recognize the fungal components in the cytosol of the cells.
b) Activation of innate immune cells: Upon recognizing A. flavus, the innate immune cells are activated and secrete cytokines, chemokines, and antimicrobial peptides that recruit and activate other immune cells at the site of infection. Neutrophils are the first cells to be recruited, and they phagocytose and kill the fungal spores by producing reactive oxygen species (ROS) and releasing antimicrobial peptides.
c) Interference with an innate immune response: A. flavus can interfere with the innate immune response by producing various virulence factors, such as gliotoxin, that can suppress immune function and inhibit the activity of neutrophils and macrophages.
Adaptive immune response:
a) Activation of T cells: Once the A. flavus spores are phagocytosed by the innate immune cells, they are processed and presented to the T cells by the antigen-presenting cells (APCs) in the lymph nodes. The T cells recognize the fungal antigens through their T cell receptors (TCRs) and become activated.
b) Differentiation of T cells: The activated T cells differentiate into various subsets, including CD4+ T helper cells and CD8+ cytotoxic T cells, depending on the type of antigen presented and the cytokine milieu. CD4+ T helper cells differentiate into Th1, Th2, Th17, or Treg cells, which secrete cytokines that help to activate other immune cells and control the immune response to A.
c) Production of antibodies: B cells are activated by the Aspergillus flavus antigens and differentiate into plasma cells, which produce antibodies that can bind to and neutralize the fungus.
d) Immune memory: Once the immune response has cleared the Aspergillus flavus infection, memory T and B cells are generated to recognize the fungus upon re-exposure and mount a more rapid and effective response.
Aspergillus flavus is known to cause various diseases in humans and animals, including invasive aspergillosis, non-invasive aspergillosis, aspergilloma, and allergic bronchopulmonary aspergillosis.
Invasive pulmonary aspergillosis: Aspergillus flavus is one of the most common causes of invasive pulmonary aspergillosis (IPA), a severe fungal infection of the lungs that can occur in immunocompromised patients, such as those with leukemia, lymphoma, or undergoing bone marrow transplantation. IPA can cause symptoms such as cough, fever, chest pain, shortness of breath, and hemoptysis. The infection can spread to other organs, such as the brain, kidneys, or liver, leading to multi-organ failure.
Sinusitis: It is a fungal infection of the sinuses that can cause nasal congestion, facial pain, headache, and fever. The infection can spread to the eye or brain, causing vision loss or neurological symptoms.
Otitis externa: An outer ear canal infection that can cause pain, itching, and discharge.
Onychomycosis: The infection of the nails that express discoloration, thickening, and separation of the nail from the nail bed.
Cutaneous infections: A. flavus can cause cutaneous infections, such as folliculitis, abscesses, or cellulitis, in immunocompromised patients.
Allergic bronchopulmonary aspergillosis: In some patients, A. flavus can cause a hypersensitivity reaction to the fungal antigens that can cause wheezing, coughing, and shortness of breath.
Diagnosing Aspergillus flavus infection requires a combination of clinical features, radiological findings, and laboratory tests. Here are some of the standard methods for diagnosing A. flavus infection:
Fungal culture: It is the gold standard for diagnosing A. flavus infection. Using selective fungal media, the fungus can be isolated from clinical specimens, such as sputum, bronchoalveolar lavage (BAL) fluid, blood, or tissues. The culture can be confirmed by microscopic examination and species identification using molecular or biochemical methods.
Antigen detection: A. flavus produces several cell wall antigens that can be detected in infected patients’ serum or BAL fluid using immunoassays such as enzyme-linked immunosorbent assay (ELISA). The most used antigen is galactomannan, a polysaccharide specific to Aspergillus species.
Molecular assays: Assays, such as polymerase chain reaction (PCR) or real-time PCR, can detect Aspergillus DNA in clinical specimens with high sensitivity and specificity. These assays can also differentiate between Aspergillus species and detect mutations that confer resistance to antifungal drugs.
Imaging studies: Imaging studies, such as chest X-ray, computed tomography (CT), or magnetic resonance imaging (MRI), can detect the characteristic features of A. flavus infection, such as nodules, cavities, or infiltrates. These studies can also assess the extent and severity of the infection and guide the treatment selection.
Histopathology: It can provide a definitive diagnosis of A. flavus infection by demonstrating the presence of fungal elements, such as hyphae, spores, or tissue invasion, in biopsy or autopsy specimens. Histopathology can also identify the host response to the infection, such as necrosis, granulomatous inflammation, or angioinvasion.
Proper storage and handling of food products:A. flavus can contaminate crops and food products, such as nuts, grains, and spices, during storage and handling. Storing food products in cool and dry environments is essential to prevent contamination. Inspecting them regularly for signs of mold growth or spoilage and discarding any contaminated or expired items.
Proper ventilation and maintenance of indoor environments:A. flavus can grow in damp or poorly ventilated indoor environments, such as bathrooms, kitchens, and basements. Maintaining proper ventilation and humidity levels is crucial to prevent its growth, repair leaks or water damage, and regularly clean and disinfect surfaces.
Personal hygiene:A. flavus can also spread from person to person through contact with contaminated surfaces or respiratory secretions. To prevent transmission, practicing good personal hygiene, such as washing hands regularly, covering coughs and sneezes, and avoiding close contact with sick individuals, is essential.
Use of antifungal agents: These are used to control Aspergillus flavus in agricultural and industrial settings, such as in the production of crops or building materials. These agents can prevent the growth and spread of the fungus and reduce the risk of exposure to workers and consumers.
https://en.wikipedia.org/wiki/Aspergillus_flavus
https://pubmed.ncbi.nlm.nih.gov/21513456
Loading...
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
